18.37
3.01%
-0.57
Dopo l'orario di chiusura:
18.40
0.03
+0.16%
Precedente Chiudi:
$18.94
Aprire:
$18.98
Volume 24 ore:
640.33K
Relative Volume:
0.68
Capitalizzazione di mercato:
$1.25B
Reddito:
-
Utile/perdita netta:
$-201.59M
Rapporto P/E:
-4.1941
EPS:
-4.38
Flusso di cassa netto:
$-139.21M
1 W Prestazione:
+6.31%
1M Prestazione:
+6.49%
6M Prestazione:
+82.97%
1 anno Prestazione:
+110.42%
Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile
Nome
Phathom Pharmaceuticals Inc
Settore
Industria
Telefono
(877) 742-8466
Indirizzo
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-08-09 | Iniziato | H.C. Wainwright | Buy |
2023-05-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
2023-03-13 | Iniziato | Craig Hallum | Buy |
2022-10-21 | Iniziato | Jefferies | Buy |
2022-05-06 | Downgrade | Evercore ISI | Outperform → In-line |
2021-05-12 | Aggiornamento | Goldman | Sell → Neutral |
2021-02-17 | Iniziato | BMO Capital Markets | Outperform |
2021-02-02 | Iniziato | Guggenheim | Buy |
2020-06-26 | Downgrade | Goldman | Neutral → Sell |
2019-11-20 | Iniziato | Evercore ISI | Outperform |
2019-11-19 | Iniziato | Goldman | Neutral |
2019-11-19 | Iniziato | Jefferies | Buy |
2019-11-19 | Iniziato | Needham | Buy |
Mostra tutto
Phathom Pharmaceuticals Inc Borsa (PHAT) Ultime notizie
Jennison Associates LLC's Strategic Acquisition in Phathom Pharm - GuruFocus.com
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewswire
Investors bid Phathom Pharmaceuticals (NASDAQ:PHAT) up US$75m despite increasing losses YoY, taking one-year return to 96% - Yahoo Finance
Phathom Pharmaceuticals (PHAT) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
PHAT SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action InvestigationPHAT - Marketscreener.com
Phathom Pharmaceuticals to Report Third Quarter 2024 - GlobeNewswire
Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business - The Bakersfield Californian
Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024 - StockTitan
Phathom Pharmaceuticals to Present VOQUEZNA® Data at the - GlobeNewswire
Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting - Yahoo Finance
Where are the Opportunities in (PHAT) - Stock Traders Daily
Shareholders have faith in loss-making Phathom Pharmaceuticals (NASDAQ:PHAT) as stock climbs 6.6% in past week, taking one-year gain to 74% - Simply Wall St
Creative Planning Has $278,000 Stock Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 6.8%Time to Buy? - MarketBeat
Certain Common Stock of Phathom Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 18-OCT-2024. - Marketscreener.com
Phathom Pharmaceuticals Inc [PHAT] Investment Appeal on the Rise - Knox Daily
A year in review: Phathom Pharmaceuticals Inc (PHAT)’s performance in the last year - US Post News
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 3.4%Time to Sell? - MarketBeat
PHAT’s 52-Week Rollercoaster: From $6.07 to $19.71 – What’s Next for Investors? - The InvestChronicle
Financial Health Report: Phathom Pharmaceuticals Inc (PHAT)’s Ratios Tell a Tale - The Dwinnex
Learn to Evaluate (PHAT) using the Charts - Stock Traders Daily
A stock that deserves closer examination: Phathom Pharmaceuticals Inc (PHAT) - US Post News
PHAT Stock Sees Decline of Approximately -13.44% in Last Five Days - Knox Daily
PHAT Stock: A Comprehensive Analysis and Forecast - The InvestChronicle
PHAT (Phathom Pharmaceuticals Inc) may reap gains as insiders became active recently - Knox Daily
Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Down 7.5%Here's What Happened - MarketBeat
Daily Market Movement: Phathom Pharmaceuticals Inc (PHAT) Sees a -4.96 Decrease, Closing at 17.25 - The Dwinnex
A new trading data show Phathom Pharmaceuticals Inc (PHAT) is showing positive returns. - SETE News
Marshall Wace LLP Invests $1.16 Million in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat
Phathom Pharmaceuticals Inc Inc. (PHAT) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Up 4.8%Here's Why - MarketBeat
The Potential Rise in the Price of Phathom Pharmaceuticals Inc (PHAT) following insiders activity - Knox Daily
Have you been able to find a good deal on Phathom Pharmaceuticals Inc’s shares? - US Post News
Phathom Pharmaceuticals Inc (PHAT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Its Stock Has Paid Off Big Time For Phathom Pharmaceuticals Inc - SETE News
Phathom Pharmaceuticals Inc (PHAT)’s stock chart: A technical perspective - US Post News
Phathom's Voquezna: A Breakthrough Drug Facing Marketing Challenges (NASDAQ:PHAT) - Seeking Alpha
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) - PR Newswire
Federated Hermes Inc. Cuts Stock Holdings in Hilton Grand Vacations Inc. (NYSE:HGV) - Defense World
Dimensional Fund Advisors LP Grows Stock Position in Koninklijke Philips (NYSE:PHG) - MarketBeat
Rhumbline Advisers Has $710,000 Stock Holdings in Koninklijke Philips (NYSE:PHG) - Defense World
Philips Must Face Investor Suit Over FDA Compliance Issues - Law360
PulteGroup Inc [PHM] Insider FOLLIARD THOMAS J sells 19,000 Shares – Latest News - Knox Daily
Citi resumes HPE stock coverage with Neutral rating and $20 price target - Invezz
What You Didn’t Know About Hewlett Packard Enterprise Co (NYSE: HPE) This Week - Stocks Register
Oracle Investment Management Inc. Invests $2.32 Million in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - MarketBeat
Koninklijke Philips (NYSE:PHG) Shares Bought by Vanguard Personalized Indexing Management LLC - Defense World
Kayne Anderson Rudnick Investment Management LLC Has $443,000 Position in Koninklijke Philips (NYSE:PHG) - Defense World
HashiCorp (NASDAQ:HCP) Receives New Coverage from Analysts at StockNews.com - MarketBeat
Fidelis Capital Partners LLC Sells 155 Shares of Hilton Worldwide Holdings Inc. (NYSE:HLT) - Defense World
Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 4% - MarketBeat
Phathom Pharmaceuticals Inc Azioni (PHAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):